David joined Results Healthcare in 2019, and has 20 years of investment banking experience, having begun his career at ING Barings. David has advised clients across private and public markets on pharma services, healthcare infrastructure, care services, medical technology and cross-border transactions.
For the last 9 years, David has specialised in healthcare M&A, most recently at DC Advisory as an Executive Director and Healthcare lead, where he co-ordinated an international team of healthcare and life sciences specialists. Clients have included public companies (Instem plc, UDG plc, System C Healthcare plc), Private Equity funds (August Equity, Livingbridge, Graphite Capital) and infrastructure funds (Antin Infrastructure Partners, iCON Infrastructure).
David received an MA Hons in History from the University of Edinburgh.
Herman Melville says somewhere in The White Whale that a man ought to be “a patriot to heaven,” and I believe it is a good thing, this ambition to be cosmopolitan, this idea to be citizens not of a small parcel of the world… but to feel that the whole world is our country. - Jorge Luis Borges
Pharma Commercialisation Services Update – February 2022
We are pleased to introduce you to the first of our regular sector updates on the outsourced pharma commercialisation sector. For some time, Results Healthcare has been producing sector updates and whitepapers on the two other major areas pharmaceutical companies choose to outsource: manufacturing and research. This report focuses on commercialisation, encompassing Healthcare Marketing, Market […]
The next chapter: Changing market dynamics in commercialisation and medical communications
The last twelve months have been a time of extraordinary activity in the commercialisation sector – the COVID-19 pandemic saw medcomms groups play a crucial part in keeping pharma companies connected with patients and healthcare professionals, and dealmaking was frenetic on both sides of the Atlantic, for smaller agencies as well as for emerging ‘CCOs’. […]
Investment in the care services sector
As a sector for external investment, the UK Care Services market hardly has novelty value – the sector has been shaped for decades by successive waves of capital from private and institutional investors. Equally, while success stories proliferate, there have been several high profile failures, of which the Four Seasons saga is only the most […]
Children’s Services Market Review
Children’s Services has been one of the more resilient areas within UK care over the last 2 years, and also one of the most active for M&A. Our recent webinar looked at how businesses in the sector have faced the challenges posed by the COVID-19 outbreak, how conditions might look as the lock-down eases, and […]
The outlook for Childen’s Services providers post COVID-19
Children’s Services has been one of the more resilient areas within UK care over the last 2 years, and also one of the most active for M&A. This webinar looks at how businesses in the sector have faced the challenges posed by the COVID-19 outbreak, how conditions might look as the lock-down eases, and the […]
The future of private equity investment in healthcare
Private equity investment in healthcare has been a driving force behind growth in the sector in recent years (read our article on the topic), and despite COVID-19, the capital available for investment is at record levels. Structural change will always create opportunity as well as challenges, and private equity should be well placed to help […]